%D9%81%D9%8A%D9%86%D9%88%D8%B1%D9%84%D8%A8%D9%8A%D9%86FinorelbinVinorelbinVinorelbineVinorelbina%D9%88%DB%8C%D9%86%D9%88%D8%B1%D9%84%D8%A8%DB%8C%D9%86VinorelbiiniVinorelbineVinorelbina%E3%83%93%E3%83%8E%E3%83%AC%E3%83%AB%E3%83%93%E3%83%B3%E0%AC%AD%E0%AC%BE%E0%AC%87%E0%AC%A8%E0%AD%8B%E0%AC%B0%E0%AD%87%E0%AC%B2%E0%AC%AC%E0%AC%BF%E0%AC%A8WinorelbinaVinorelbinaVinorelbin%C4%83%D0%92%D0%B8%D0%BD%D0%BE%D1%80%D0%B5%D0%BB%D0%B1%D0%B8%D0%BDVinorelbinVinorelbin%D0%92%D1%96%D0%BD%D0%BE%D1%80%D0%B5%D0%BB%D1%8C%D0%B1%D1%96%D0%BDVinorelbineQ420532
about
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk RhabdomyosarcomaVinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer PatientsStudy of Re-irradiation at Relapse Versus RT and Multiple Elective rt CoursesPhase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin LymphomaMetronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell LymphomasSafety Study of Oral Vinorelbine in Subjects With Non-Hematologic MalignanciesA Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's LymphomaPhase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLCStudy With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer PatientsVinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast CancerSafety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast CancerEfficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast CancerStudy of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's DiseaseFirst-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung CancerChemotherapy in Treating Patients With Lung CancerA Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung CancerLapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast CancerPhase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™)Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung CancerCapecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast CancerChemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung CancerTo Evaluate the Efficacy and Safety of Gefitinib in Adjuvant Chemotherapy for Lung AdenocarcinomaChemotherapy With Pembrolizumab Continuation After Progression to PD-1/L1 InhibitorsApatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung CancerAn Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual DiseaseVinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast CancerCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate CancerVaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast CancerCarboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerS9804: Vinorelbine in Treating Patients With Stage IV MelanomaVinorelbine in Treating Patients With Metastatic Prostate CancerBBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)Vinorelbine in Treating Patients With Metastatic or Advanced Solid TumorsVinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the PelvisCombination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney CancerCombination Chemotherapy in Treating Patients With Advanced CancerVinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCombination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical CancerVinorelbine in Advanced BRAF-like Colon CancerVinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer
P4844
Q61862239-6FDB9FB9-0505-4AA8-BE92-C61E0E95E00EQ61865300-A70E4820-E526-4342-8506-9CDEBA5B2A73Q61902724-B408360B-247D-4FA3-B6F3-40133A17F5A0Q61902861-F98982FD-EA1B-40A7-AE85-18DC056B1BC1Q61909217-726557B1-4254-4A8D-93DC-A1B98CBE5908Q61914849-A1A7DC90-A05A-4769-9241-A218BA7768FAQ61915337-950DFADC-1E31-49F8-88B5-65AC7E4CA133Q61917500-15EBFBC1-C167-4825-995C-065A472E508BQ61920784-2097B154-C442-4022-90CC-AC9F032038E2Q61921138-E5EC925D-52FE-4804-9A56-0204CA746D96Q61921427-5F6D34C0-E266-4FDC-B816-59077D75EDADQ61932980-CEED2F00-3135-4FB3-97A4-2C287330A03BQ61934460-138C7B56-5569-45EF-9AF3-6E5BC5AD0E0CQ61936447-FAD4D39C-B7A6-4EFE-BA4B-C9AC5B949DC3Q61939106-73BAE21C-7F7E-4ED0-B94A-060ED78DEBF4Q61966243-7F722075-09A3-4B79-9212-B287A7BD583FQ61978988-55F0F975-DB7F-4CFD-80FF-C48ADE7B9D28Q61980138-7B0BEDCD-1D83-4960-9463-D4F7CD692909Q61980635-75A7634A-95C9-4F58-8B00-8BD7B1E89DE7Q61980791-9CD72820-E9C0-44FF-A101-BFE4731BD93EQ61981237-B5EEA03F-CF3E-4D7F-A02E-9F68FC9010EFQ62024897-DD4570F8-DCDD-4E0A-96BF-3874C7995E8BQ62024922-2567AC47-F31C-4C18-BA3B-8EB3D7E15398Q62025217-049DFF7F-BD46-4931-ADD3-B763EC813928Q62031403-33531F26-6D46-4847-9F30-423B20DAD1F9Q62106077-A6AA95CB-7B10-4A5E-A301-86C3778EA5B0Q62109991-B745BDA3-8FE4-4BE7-A616-3E7508DFEC06Q62110101-C316FE87-760C-4009-BFDE-63B1D76B4415Q62110122-9B03B88B-BA84-4425-8B06-F86087E1FAF7Q62110129-53DD9C6E-A2F0-49A1-9F3A-337CD6CD3EE5Q62110175-2EA4CBC6-6238-4764-A471-EAD5915FCC8EQ62110198-7A55EFE0-B18F-4692-A954-501AA07C284AQ62110600-5E996BF0-2D47-4CA1-93B2-F8E2CF47480CQ62110667-5502B7E5-31D8-4715-960D-5F454742C3F4Q62110800-A78EB4AA-CE1E-4281-B08D-F67EDEA450E6Q62110959-7F880CB7-F530-4C02-B8A7-0E9E1583594AQ62111025-826143E3-C52B-4638-A4C6-67DE469BE884Q62111033-8BE1BA99-0D6F-4BE4-AAD0-8D6B85878132Q62810829-6BA6161E-DE6B-4070-8232-F5844A5464E3Q63063150-518A26D4-3130-494B-AC4A-A4E282C5E5AB
P4844
description
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
name
Vinorelbiini
@fi
Vinorelbin
@de
Vinorelbin
@sh
Vinorelbin
@sr
Vinorelbina
@pt
Vinorelbine
@it
Vinorelbine
@nl
Vinorelbină
@ro
finorelbin
@cy
vinorelbin
@cs
type
label
Vinorelbiini
@fi
Vinorelbin
@de
Vinorelbin
@sh
Vinorelbin
@sr
Vinorelbina
@pt
Vinorelbine
@it
Vinorelbine
@nl
Vinorelbină
@ro
finorelbin
@cy
vinorelbin
@cs
altLabel
5'-Noranhydrovinblastine
@cy
5'-Noranhydrovinblastine
@en
71486-22-1
@fr
C45H54N4O8
@fr
Navelbine
@de
Navelbine
@fr
Nor-5'-anhydrovinblastine
@cy
Nor-5'-anhydrovinblastine
@en
Vinorelbine
@de
Vinorelbintartrat
@de
prefLabel
Vinorelbiini
@fi
Vinorelbin
@de
Vinorelbin
@sh
Vinorelbin
@sr
Vinorelbina
@pt
Vinorelbine
@it
Vinorelbine
@nl
Vinorelbină
@ro
finorelbin
@cy
vinorelbin
@cs
P2175
P31
P486
P592
P6366
P646
P661
P662
P665
P683
P1579
P2115
N0000021986
P231
71486-22-1
P234
1S/C45H54N4O8/c1-8-27-19-28-22 ...... ,38+,39+,42+,43+,44-,45-/m0/s1
P235
GBABOYUKABKIAF-IELIFDKJSA-N